Abstract
One of the major functions of marketing strategy is the proper positioning of the company in the sectorial value‐added chain, in order to create the best possible competitive advantage. This process is extremely important, especially for small and medium‐sized enterprises (SMEs), since any wrong decision can literally eliminate the company from the market. This paper attempts to analyse and present the strategic positioning process specific to small and medium‐sized biopharmaceutical firms in the UK. After discussing the specific characteristics of the value chain in the biopharmaceuticals sector, the paper presents the research methodology used to collect primary and secondary data. Data analysis leads towards a theoretical model that describes the stages and the factors influencing the strategic positioning of SMEs in the value‐added chain of the biopharmaceuticals sector.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
